arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

LABCORP HOLDINGS INC.

LH
$363.30 ▼ -4.50 (-1.22%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
19 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

LABCORP HOLDINGS INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $30.2B
Dividend Yield 0.79%
Revenue Growth 7.2% ↗
Op. Margin 9.9% ↗
ROIC 8.0% ↗
FCF / Share $14.50 ↗
Trailing P/E 34.5x
Price / Book 3.5x
FCF Yield 4.0%
Debt / Equity 0.59
info Valuation on last close. End-of-day price, Nov 5, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.95B
↑ +7.2% —
Net Income Profit after all expenses
$876.50M
↑ +17.5% —
Operating Margin Operating profit as % of sales
9.9%
↑ +18.8% 56th
FCF / Share Free cash flow per share
$14.50
↑ +11.0% —
Long-Term Debt Long-term obligations
$5.08B
↓ -4.6% —

Health Breakdown

Profitability ↓
55
Returns ↓
68
Financial Health →
61
Cash Quality ↑
78

Dividend History

Dividend / share · sourced from SEC filings
$2.88 Latest / share
+0.0% YoY
+0.0% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 19 years · 73 quarters